Pharmacokinetic interaction of AFQ 056 with levodopa/carbidopa in volunteers

Trial Profile

Pharmacokinetic interaction of AFQ 056 with levodopa/carbidopa in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Jul 2012

At a glance

  • Drugs Mavoglurant (Primary) ; Levodopa/carbidopa
  • Indications Parkinson's disease
  • Focus Pharmacokinetics
  • Most Recent Events

    • 31 Jul 2012 New trial record
    • 21 Jun 2012 Results presented at the 16th International Congress of Parkinson's Disease and Movement Disorders.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top